Understanding the Causes and Treatment of Ovarian Cancer
September 19, 2019
Early Detection is Key to Recovery
Breaking News
- L.A. Sentinel and FACE Leaders Unite to ‘Stop the Hate’ Crimes in Los Angeles
- Fathers and Mothers Who Care Host 12th Annual Toy Giveaway in Compton
- Community in Shock and Disbelief Over Allegations Regarding Deputy Mayor Brian K. Williams
- LACMA Showcases ‘Imagining Black Diasporas: 21st-Century Art and Poetics’ Exhibit
- Sheenway School and Culture Center — Educating Youth to Lead the Future Over 50 Years
- Record-Breaking Hate Crimes Against Black Angelenos on the Rise
- Los Angeles Rams and LAPD Spread Holiday Cheer with Annual Sleigh Ride
- Heather Hutt Sworn-in as Councilwoman for L.A.’s 10th District
- Visit Baldwin Hills Crenshaw Plaza for Holiday Photos with Santa
- Homeless and Their Advocates Speak Out in New Film, ‘WE, the Vulnerable of LA’
- The Congressman Wore Sneakers: An Evening With Hakeem Jeffries
- Brotherhood Crusade Honors SEIU President April Verrett at 2024 Pioneer of African American Achievement Award Dinner
- USC Men’s Basketball Wins Fourth Straight; Beats Southern University 82-51
- Deadly Violence in Nigeria Linked to Breakup of United Methodist Church Over LGBTQ Policies
- Black Denomination Upholds Stance Against Same-Sex Marriage. A Gay Pastor in its Ranks Seeks Change
- California Cannot Afford to Ignore Its Water Crisis
ovarian cancer
Assemblywomen Autumn Burke and Marie Waldron Demand More Genetic Testing for Women with a High Risk of Ovarian and Breast Cancer
March 8, 2018
Assemblywomen Autumn Burke (D- Inglewood) and Marie Waldron (R- Escondido) have introduced AB 2342 ensuring that women who have not been diagnosed with breast or ovarian cancer, but who could be considered high-risk are appropriately assessed and if necessary, receive genetic counseling and testing.